Breast cancer treatment resistance linked to signalling pathway
Tuesday, September 23, 2008 - 08:14
in Health & Medicine
Activation of the Src signalling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented here at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting...
Read the whole article on Science Centric
More from Science Centric
Related
- Breast cancer treatment resistance linked to signaling pathwayTue, 23 Sep 2008, 0:28:36 EDT
- New breast cancer-promoting gene identifiedMon, 20 Jul 2009, 17:38:19 EDT
- TG2 identified as potential therapeutic target in chemo-resistant ovarian cancerTue, 15 Jul 2008, 9:08:24 EDT
- Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1Fri, 22 Aug 2008, 12:57:03 EDT
- Hitting where it hurts: Exploiting cancer cell 'addiction' may lead to new therapiesMon, 1 Jun 2009, 12:30:56 EDT